SuperworthValion Bio shares outstanding VBIO
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2025
- 35.3K
- On a year earlier
- +273.6%
- more shares
Valion Bio had 35.3K diluted shares outstanding on average in Q2 FY25, the quarter to Jun 30, 2025.
That is 273.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 18.4K | −69% |
| FY2023 | 58.6K | +1412% |
| FY2022 | 3.9K | +46% |
| FY2021 | 2.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY25 | 35.3K | +274% | |
| Q1 FY25 | 23.9K | +591% | |
| Q4 FY24 | 18.4K | −69% | |
| Q3 FY24 | 247.6K | +420% | |
| Q2 FY24 | 9.4K | −21% | |
| Q1 FY24 | 3.5K | −57% | |
| Q4 FY23 | 58.6K | +1412% | |
| Q3 FY23 | 47.6K | +1129% | |
| Q2 FY23 | 11.9K | +208% | |
| Q1 FY23 | 8K | +107% | |
| Q4 FY22 | 3.9K | +46% | |
| Q3 FY22 | 3.9K | +275% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Valion Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.